Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 9 of 9 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company BioMedomics Inc. | Activity: Research and Development | Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. | Location Morrisville | |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham | |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham | |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh | |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh | |
Company HemoSonics LLC | Activity: Research and Development | Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care. | Location Durham | |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham | |
Company Kalia Health | Activity: Research and Development | Company Description Kalia Health develops home-based early detection tests for pregnancy complications like preeclampsia and eclampsia for use in low-resource settings. | Location Chapel Hill | |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville |